Splicing factor 2/alternative splicing factor contributes to extracellular signal-regulated kinase activation in hepatocellular carcinoma cells
Yawei Zhao(Jilin University), Yuanfang Ma(Shenyang Agricultural University)
Cited by 3
Related Papers
Gypenosides improve diabetic cardiomyopathy by inhibiting <scp>ROS</scp>‐mediated <scp>NLRP</scp>3 inflammasome activation
|Journal of Cellular and Molecular Medicine|2018|169
Blocking p38 Signaling Reduces the Activation of Pro-inflammatory Cytokines and the Phosphorylation of p38 in the Habenula and Reverses Depressive-Like Behaviors Induced by Neuroinflammation
|Frontiers in Pharmacology|2018|50
PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress
|Oncology Letters|2016|36
Fingolimod targets cerebral endothelial activation to block leukocyte recruitment in the central nervous system
|Journal of Leukocyte Biology|2017|24